Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: The TACT randomized trial

JAMA

Volumn 309, Issue 12, 2013, Pages 1241-1250

  Lamas, Gervasio A ^a   Goertz, Christine ^b   Boineau, Robin ^c   Mark, Daniel B ^e   Rozema, Theodore ^f   Nahin, Richard L ^d   Lindblad, Lauren ^e   Lewis, Eldrin F ^g   Drisko, Jeanne ^h   Lee, Kerry L ^e  

^a Mount Sinai Medical Center ^*  (United States)

^b PALMER CENTER FOR CHIROPRACTIC RESEARCH   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d National Advisory Council for Complementary and Alternative Medicine   (United States)

^e DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^f Biogenesis Medical Center   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; BICARBONATE; EDETATE DISODIUM; ELECTROLYTE; HEPARIN; MAGNESIUM CHLORIDE; PANTOTHENIC ACID; PLACEBO; POTASSIUM CHLORIDE; PROCAINE; PYRIDOXINE; THIAMINE; VITAMIN B GROUP; CHELATING AGENT; EDETIC ACID;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHELATION THERAPY; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPOCALCEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK REDUCTION; TREATMENT DURATION; TREATMENT RESPONSE; ATHEROSCLEROSIS; CONTROLLED CLINICAL TRIAL; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; RISK; STATISTICS; TREATMENT OUTCOME;

AGED; ANGINA PECTORIS; ATHEROSCLEROSIS; CHELATING AGENTS; DOUBLE-BLIND METHOD; EDETIC ACID; FEMALE; HOSPITALIZATION; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; RECURRENCE; RISK; STROKE; TREATMENT OUTCOME;

EID: 85047688253     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.2107     Document Type: Article

References (38)

1. Bessman SP, Ried H, Rubin M. Treatment of lead encephalopathy with calcium disodium versenate; report of a case. Med Ann Dist Columbia. 1952;21(6):312-315.
2. Clarke NE, Clarke CN, Mosher RE. The in vivo dissolution of metastatic calcium; an approach to atherosclerosis. Am J Med Sci. 1955;229(2):142-149.
3. Clarke CN, Clarke NE, Mosher RE. Treatment of angina pectoris with disodium ethylene diamine tetraacetic acid. Am J Med Sci. 1956;232(6):654-666.
4. Casdorph HR. EDTA chelation therapy: efficacy in arteriosclerotic heart disease. J Holistic Med. 1981;3:53.
5. Grier MT, Meyers DG. So much writing, so little science: a review of 37 years of literature on edetate sodium chelation therapy. Ann Pharmacother. 1993;27(12):1504-1509. (Pubitemid 24005152)
6. Rudolph CJ, McDonagh EW, Barber RK. A non-surgical approach to obstructive carotid stenosis using EDTA chelation. J Adv Med. 1991;4:157-166.
7. Cranton EM, ed. A Textbook on EDTA Chelation Therapy. Newburyport, MA: Hampton Roads Publishing; 2001;2:503-539.
8. Rudolph CJ, McDonagh EW, Barber RK. Effect of EDTA chelation on serum iron. J Adv Med. 1991;4:39-45.
9. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007 Natl Health Stat Report. 2008;(12):1-23.
10. Guldager B, Jelnes R, Jørgensen SJ, et al. EDTA treatment of intermittent claudication - a double-blind, placebo-controlled study. J Intern Med. 1992;231(3):261-267.
11. van Rij AM, Solomon C, Packer SG, Hopkins WG. Chelation therapy for intermittent claudication: a double-blind, randomized, controlled trial. Circulation. 1994;90(3):1194-1199. (Pubitemid 24284440)
12. Knudtson ML, Wyse DG, Galbraith PD, et al Program to Assess Alternative Treatment Strategies to Achieve Cardiac Health Investigators. Chelation therapy for ischemic heart disease: a randomized controlled trial. JAMA. 2002;287(4):481-486. (Pubitemid 34251987)
13. American Heart Association. Questions and Answers About Chelation Therapy. Dallas, TX: American Heart Association; 2000.
14. Centers for Disease Control and Prevention. Deaths associated with hypocalcemia from chelation therapy - Texas, Pennsylvania, and Oregon, 2003-2005. MMWR Morb Mortal Wkly Rep. 2006;55(8):204-207.
15. Lamas GA, Goertz C, Boineau R, et al. Design of the Trial to Assess Chelation Therapy (TACT). Am Heart J. 2012;163(1):7-12.
16. Rozema TC. Special issue: protocols for chelation therapy. J Adv Med. 1997;10:5-100.
17. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. 2nd ed. New York, NY: John Wiley & Sons Inc; 2002.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
19. Cox DR. Regression models and life-tables (with discussion). J R Stat Soc B. 1972;34:187-220.
20. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics. 1979;35(3):549-556. (Pubitemid 10242750)
21. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika. 1983;70:659-663.
22. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK; Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345(7):494-502. (Pubitemid 32758501)
23. Kitchell JR, Palmon F Jr, Aytan N, Meltzer LE. The treatment of coronary artery disease with disodium EDTA: a reappraisal. Am J Cardiol. 1963;11:501-506.
24. Lamar CP. Chelation endarterectomy for occlusive atherosclerosis. J Am Geriatr Soc. 1966;14(3):272-294.
25. Casdorph HR, Farr CH. EDTA chelation therapy III: treatment of peripheral arterial occlusion, an alternative to amputation. J Holistic Med. 1983;5:3.
26. Olszewer E, Carter JP. EDTA chelation therapy in chronic degenerative disease. Med Hypotheses. 1988;27(1):41-49.
27. US Food and Drug Administration. Public Health Advisory: edetate disodium (marketed as endrate and generic products). http://www.fda.gov/OHRMS/DOCKETS/ 98fr/E8-13273.htm. Accessed February 22, 2013.
28. Qaseem A, Fihn SD, Dallas P, et al. Management of stable ischemic heart disease: summary of a clinical practice guideline from the American College of Physicians, American College of Cardiology Foundation/American Heart Association/American Association for Thoracic Surgery/Preventive Cardiovascular Nurses Association/Society of Thoracic Surgeons. Ann Intern Med. 2012;157(10):735-743.
29. Menke A, Muntner P, Batuman VV, Silbergeld EK, Guallar E. Blood lead below 0.48 μmol/L (10 μg/dL) and mortality among US adults. Circulation. 2006;114(13):1388-1394. (Pubitemid 44454558)
30. Weisskopf MG, Jain N, Nie H, et al. A prospective study of bone lead concentration and death from all causes, cardiovascular diseases, and cancer in the Department of Veterans Affairs Normative Aging Study. Circulation. 2009;120(12):1056-1064.
31. Agarwal S, Zaman T, Tuzcu EM, Kapadia SR. Heavy metals and cardiovascular disease: results from the National Health and Nutrition Examination Survey (NHANES) 1999-2006. Angiology. 2011;62(5):422-429.
32. Anderson TJ, Hubacek J, Wyse DG, Knudtson ML. Effect of chelation therapy on endothelial function in patientswith coronary artery disease: PATCH substudy. J Am Coll Cardiol. 2003;41(3):420-425. (Pubitemid 36164496)
33. Plantinga Y, Ghiadoni L, Magagna A, et al. Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients. Am J Hypertens. 2007;20(4):392-397. (Pubitemid 46442896)
34. Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney JF Jr, Vita JA. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 1996;93(6):1107-1113. (Pubitemid 26087013)
35. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 2007;297(8):842-857. (Pubitemid 46333949)
36. Sesso HD, Christen WG, Bubes V, et al. Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA. 2012;308(17):1751-1760.
37. Padayatty SJ, Sun H, Wang Y, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004;140(7):533-537.
38. Yoshida H, Kisugi R. Mechanisms of LDL oxidation. Clin Chim Acta. 2010;411(23-24):1875-1882.